Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioMarin Pharmaceutical Inc. BMRN

Full chart Compare
Set alert

Price alert · BMRN

All alert types
56.12 USD -1.01 (-1.77%)

At closeNov 6, 2026, 4:00 AM EST

55.81 -0.31 -0.55%

Pre-market · Nov 6, 4:00 AM ET

55.97 Day range 57.99
49.26 52-week range 70.98
YTD
-5.57%
1 year
+6.29%

Financial health

Altman Z-Score

1.86 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E 32.7×
FY 2016: -21.8×FY 2017: -133×FY 2018: -194×FY 2019: -650×FY 2020: 18.5×FY 2021: -252×FY 2022: 136×FY 2023: 108×FY 2024: 29.2×FY 2025: 32.7×
FY 2016 5y median 32.7× FY 2025
P/S 3.5×
FY 2016: 12.3×FY 2017: 11.8×FY 2018: 10.1×FY 2019: 8.9×FY 2020: 8.5×FY 2021: 8.8×FY 2022: 9.1×FY 2023: 7.5×FY 2024: 4.4×FY 2025: 3.5×
FY 2016 5y median 7.5× FY 2025
P/B 1.9×
FY 2016: 5.0×FY 2017: 5.5×FY 2018: 5.1×FY 2019: 4.8×FY 2020: 3.9×FY 2021: 3.8×FY 2022: 4.2×FY 2023: 3.7×FY 2024: 2.2×FY 2025: 1.9×
FY 2016 5y median 3.7× FY 2025
P/FCF 15.7×
FY 2016: -36.5×FY 2017: -74.8×FY 2018: -121×FY 2019: -156×FY 2020: -304×FY 2021: 87.2×FY 2022: 349×FY 2023: 351×FY 2024: 26.3×FY 2025: 15.7×
FY 2016 5y median 87.2× FY 2025
EV/EBITDA 18.7×
FY 2016: -20.1×FY 2017: 177×FY 2018: -4574×FY 2019: 487×FY 2020: 195×FY 2021: 351×FY 2022: 73.6×FY 2023: 60.1×FY 2024: 18.7×FY 2025: 18.7×
FY 2016 5y median 60.1× FY 2025
EV/Sales 3.3×
FY 2016: 12.6×FY 2017: 12.3×FY 2018: 10.3×FY 2019: 9.1×FY 2020: 8.8×FY 2021: 9.0×FY 2022: 9.3×FY 2023: 7.6×FY 2024: 4.3×FY 2025: 3.3×
FY 2016 5y median 7.6× FY 2025
FCF Yield 6.4%
FY 2016: -2.7%FY 2017: -1.3%FY 2018: -0.8%FY 2019: -0.6%FY 2020: -0.3%FY 2021: 1.1%FY 2022: 0.3%FY 2023: 0.3%FY 2024: 3.8%FY 2025: 6.4%
FY 2016 5y median 1.1% FY 2025

Profitability

Gross Margin 77.1%
FY 2016: 81.2%FY 2017: 81.6%FY 2018: 78.9%FY 2019: 78.9%FY 2020: 71.8%FY 2021: 74.5%FY 2022: 76.0%FY 2023: 78.0%FY 2024: 79.7%FY 2025: 77.1%
FY 2016 5y median 77.1% FY 2025
Operating Margin 16.6%
FY 2016: -71.9%FY 2017: -1.1%FY 2018: -8.3%FY 2019: -5.9%FY 2020: -2.3%FY 2021: -4.5%FY 2022: 7.7%FY 2023: 7.7%FY 2024: 17.0%FY 2025: 16.6%
FY 2016 5y median 7.7% FY 2025
Net Margin 10.8%
FY 2016: -56.4%FY 2017: -8.9%FY 2018: -5.2%FY 2019: -1.4%FY 2020: 45.9%FY 2021: -3.5%FY 2022: 6.8%FY 2023: 6.9%FY 2024: 15.0%FY 2025: 10.8%
FY 2016 5y median 6.9% FY 2025
ROE 5.7%
FY 2016: -22.8%FY 2017: -4.2%FY 2018: -2.6%FY 2019: -0.8%FY 2020: 20.8%FY 2021: -1.5%FY 2022: 3.1%FY 2023: 3.4%FY 2024: 7.5%FY 2025: 5.7%
FY 2016 5y median 3.4% FY 2025
ROIC 5.6%
FY 2016: -16.9%FY 2017: -0.4%FY 2018: -1.7%FY 2019: -0.6%FY 2020: 14.1%FY 2021: -1.3%FY 2022: 2.6%FY 2023: 2.7%FY 2024: 6.0%FY 2025: 5.6%
FY 2016 5y median 2.7% FY 2025
ROA 4.6%
FY 2016: -15.7%FY 2017: -2.5%FY 2018: -1.7%FY 2019: -0.5%FY 2020: 14.6%FY 2021: -1.1%FY 2022: 2.2%FY 2023: 2.5%FY 2024: 6.1%FY 2025: 4.6%
FY 2016 5y median 2.5% FY 2025

Growth (YoY)

Revenue 12.9%
FY 2016: 25.5%FY 2017: 17.6%FY 2018: 13.5%FY 2019: 14.3%FY 2020: 9.2%FY 2021: -0.8%FY 2022: 13.5%FY 2023: 15.4%FY 2024: 18.0%FY 2025: 12.9%
FY 2016 FY 2025
Operating Income 10.2%
FY 2016: -625.8%FY 2017: 98.2%FY 2018: -740.3%FY 2019: 18.7%FY 2020: 56.8%FY 2021: -89.6%FY 2022: 295.5%FY 2023: 15.4%FY 2024: 160.6%FY 2025: 10.2%
FY 2016 FY 2025
EPS (diluted) -18.6%
FY 2016: -254.2%FY 2017: 82.3%FY 2018: 34.3%FY 2019: 70.5%FY 2020: 3584.6%FY 2021: -107.7%FY 2022: 314.3%FY 2023: 17.3%FY 2024: 151.1%FY 2025: -18.6%
FY 2016 FY 2025
Free Cash Flow 52.5%
FY 2016: 16.3%FY 2017: 44.7%FY 2018: 40.2%FY 2019: 22.2%FY 2020: 46.1%FY 2021: 455.3%FY 2022: -70.4%FY 2023: -6.0%FY 2024: 820.5%FY 2025: 52.5%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 3.2×FY 2017: 2.7×FY 2018: 3.9×FY 2019: 2.1×FY 2020: 4.8×FY 2021: 4.2×FY 2022: 4.7×FY 2023: 2.5×FY 2024: 5.3×FY 2025: 5.2×
FY 2016 5y median 4.7× FY 2025
Quick Ratio 3.5×
FY 2016: 2.4×FY 2017: 2.1×FY 2018: 2.9×FY 2019: 1.4×FY 2020: 3.3×FY 2021: 2.7×FY 2022: 3.2×FY 2023: 1.6×FY 2024: 3.3×FY 2025: 3.5×
FY 2016 5y median 3.2× FY 2025
Debt / Equity 0.1×
FY 2016: 0.2×FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -1.2×
FY 2016: -0.4×FY 2017: 6.3×FY 2018: -99.8×FY 2019: 13.2×FY 2020: 5.2×FY 2021: 10.6×FY 2022: 1.4×FY 2023: 1.1×FY 2024: -0.5×FY 2025: -1.2×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 48.9×
FY 2016: -20.3×FY 2017: -0.3×FY 2018: -2.8×FY 2019: -4.3×FY 2020: -1.5×FY 2021: -5.4×FY 2022: 10.1×FY 2023: 10.7×FY 2024: 38.2×FY 2025: 48.9×
FY 2016 5y median 10.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31